"Pi" and Hot Flushes

NCT ID: NCT01315041

Last Updated: 2016-01-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1/PHASE2

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-12-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hot flushes are common symptoms in women after menopause, and are important causes of discomfort and lead to high number of medical consultations. Hormone replacement therapy is an effective treatment, however it can bring undesirable consequences and may be contraindicated for some women. Options are inhibitors of serotonin or serotonin-norepinephrine reuptake, gabapentin, herbal medicines and homeopathy. None of these therapies is widely accepted of effective. Therefore, the search for new therapeutic options is highly desirable. Ingestion of malagueta pepper fruits (Capsicum frutescens L. var. malagueta) causes sensations similar to those experienced by menopausal women during hot flushes. By the principle of homeopathy, "the like cures the like", the objectives of this study are: (a) to determinate whether pathogenesis of a homeopathic medicine made from C. frutescens fruits include symptoms like hot flushes, and (b) whether this medicine is effective on hot flushes relief in women after menopause. There will be 2 distinct phases. Phase 1 is the determination of the medicine's pathogenesis in healthy volunteers, in a randomized placebo-controlled, double-blind design. Phase 2 is the investigation of the medicine's effects on hot flushes of women after menopause, in a randomized placebo-controlled, double-blind design. The investigators expect a significant reduction on symptoms perception, assessed by internationally validated tools. The study is expected to last for 18 months, with 36 patients included in each phase.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menopausal Symptom Relief

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"Pi" medicine

Group Type ACTIVE_COMPARATOR

Capsicum frutescens fruits, homeopathic medicine

Intervention Type DRUG

5 drops, PO, 3 times a day, during 16 weeks

Placebo

Group Type PLACEBO_COMPARATOR

Inert alcoholic solution

Intervention Type DRUG

5 drops, PO, 3 times a day, during 16 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Capsicum frutescens fruits, homeopathic medicine

5 drops, PO, 3 times a day, during 16 weeks

Intervention Type DRUG

Inert alcoholic solution

5 drops, PO, 3 times a day, during 16 weeks

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Phase 1: healthy volunteers
* Phase 2: menopaused women with hot flushes

Exclusion Criteria

* Illiteracy;
* Have been enrolled in another clinical trial within the last 6 months;
* Use of pharmacological therapies for hot flushes;
* Have any degree of vulnerability;
* Allergy or hypersensitivity to Capsicum species;
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Sao Paulo

OTHER

Sponsor Role collaborator

Casa Espirita Terra de Ismael

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fabio Carmona

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Edson Z Martinez, PhD

Role: STUDY_DIRECTOR

University of Sao Paulo

Fabio Carmona, MD, PhD

Role: STUDY_DIRECTOR

University of Sao Paulo

Mateus A Angelucci, MD, MSc

Role: PRINCIPAL_INVESTIGATOR

University of Sao Paulo

Ana MS Pereira, PhD

Role: STUDY_CHAIR

University of Ribeirao Preto

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Casa Espirita Terra de Ismael

Jardinópolis, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pi2011

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Soy Isoflavones on Menopausal Hot Flashes
NCT00179556 COMPLETED PHASE2/PHASE3